Celina Ang

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida et al. · Hepatology · 2022 · 234 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

Celina Ang, Samuel J. Klempner, Siraj M. Ali et al. · Oncotarget · 2019 · 165 citations · Full text

Life Sciences, Immunology, Oncology +17

Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy

Sirish Dharmapuri, Umut Özbek, Jung‐Yi Lin et al. · Cancer Medicine · 2020 · 130 citations · Full text

Medicine, Hematology, Oncology +15

Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study

Sofya Pintova, Sirish Dharmupari, Erin Moshier et al. · Cancer Chemotherapy and Pharmacology · 2019 · 127 citations

Medicine, Oncology, Pharmacology +12

A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola et al. · Oncogene · 2018 · 115 citations · Full text

Medicine, Genetics, Oncology +17